Raychoudhuri et al., 2011 - Google Patents
ISG56 and IFITM1 proteins inhibit hepatitis C virus replicationRaychoudhuri et al., 2011
View PDF- Document ID
- 2136277114009188637
- Author
- Raychoudhuri A
- Shrivastava S
- Steele R
- Kim H
- Ray R
- Ray R
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
Hepatitis C virus (HCV) often leads to persistent infection. Interferon (IFN) and IFN- stimulated genes (ISGs) are amplified during HCV infection but fail to eliminate virus from the liver in a large number of infected patients. We have observed previously that HCV …
- 241000711549 Hepacivirus C 0 title abstract description 135
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Raychoudhuri et al. | ISG56 and IFITM1 proteins inhibit hepatitis C virus replication | |
| Dukhovny et al. | A CRISPR activation screen identifies genes that protect against Zika virus infection | |
| Ashour et al. | NS5 of dengue virus mediates STAT2 binding and degradation | |
| Son et al. | Double-stranded RNA is detected by immunofluorescence analysis in RNA and DNA virus infections, including those by negative-stranded RNA viruses | |
| Kumthip et al. | Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling | |
| Bhanja Chowdhury et al. | Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A | |
| Yamamoto et al. | Identification of nafamostat as a potent inhibitor of Middle East respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay | |
| Xiao et al. | The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm | |
| Chen et al. | ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment | |
| Jones et al. | Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression | |
| Suzuki et al. | Characterization of RyDEN (C19orf66) as an interferon-stimulated cellular inhibitor against dengue virus replication | |
| Pattabhi et al. | Targeting innate immunity for antiviral therapy through small molecule agonists of the RLR pathway | |
| Todt et al. | Antiviral activities of different interferon types and subtypes against hepatitis E virus replication | |
| Yu et al. | Hepatitis B virus polymerase inhibits RIG-I-and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKϵ and DDX3 | |
| Lokugamage et al. | Middle East respiratory syndrome coronavirus nsp1 inhibits host gene expression by selectively targeting mRNAs transcribed in the nucleus while sparing mRNAs of cytoplasmic origin | |
| Wang et al. | Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells | |
| Spiegel et al. | Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3 | |
| Ambrose et al. | West Nile virus differentially modulates the unfolded protein response to facilitate replication and immune evasion | |
| Ikegame et al. | Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells | |
| Boudreau et al. | Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor β-dependent manner: a new contributor to HCV-induced oxidative stress | |
| Lu et al. | Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1 | |
| Kanazawa et al. | Regulation of hepatitis C virus replication by interferon regulatory factor 1 | |
| Arita et al. | Valosin-containing protein (VCP/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infection | |
| Xue et al. | ISG12a restricts hepatitis C virus infection through the ubiquitination-dependent degradation pathway | |
| Bedard et al. | Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses |